RANKL enhances the effect of an antagonist of inhibitor of apoptosis proteins (cIAPs) in RANK-positive breast cancer cells.
about
RANKL enhances the effect of an antagonist of inhibitor of apoptosis proteins (cIAPs) in RANK-positive breast cancer cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
RANKL enhances the effect of a ...... -positive breast cancer cells.
@en
RANKL enhances the effect of an antagonist of inhibitor of apoptosis proteins
@nl
type
label
RANKL enhances the effect of a ...... -positive breast cancer cells.
@en
RANKL enhances the effect of an antagonist of inhibitor of apoptosis proteins
@nl
prefLabel
RANKL enhances the effect of a ...... -positive breast cancer cells.
@en
RANKL enhances the effect of an antagonist of inhibitor of apoptosis proteins
@nl
P2093
P2860
P1476
RANKL enhances the effect of a ...... -positive breast cancer cells.
@en
P2093
P2860
P304
P356
10.1016/J.JBO.2013.07.001
P577
2013-07-10T00:00:00Z